Release Date: 28/01/16 14:25 Summary: Consolidation/Split - MNE Price Sensitive: Yes Download Document 34.11KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%